Free Trial

Exencial Wealth Advisors LLC Grows Position in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Exencial Wealth Advisors increased its Synopsys stake by 35.6% in Q4 to 31,755 shares, worth $14.916 million, while hedge funds and institutional investors own about 85.47% of the stock.
  • Synopsys beat Q4 estimates with EPS of $3.77 (vs. $3.56 expected) and revenue of $2.41 billion (up 65.6% YoY), and set FY2026 EPS guidance of 14.380–14.460 and Q2 guidance of 3.110–3.170.
  • Analysts are mixed—consensus rating is "Hold" with an average target of $531 (8 Buys, 8 Holds, 1 Sell); the stock trades near $498.54 with a market cap of $95.5 billion and a P/E of 77.41.
  • MarketBeat previews top five stocks to own in May.

Exencial Wealth Advisors LLC boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 35.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 31,755 shares of the semiconductor company's stock after purchasing an additional 8,343 shares during the period. Exencial Wealth Advisors LLC's holdings in Synopsys were worth $14,916,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Alpine Bank Wealth Management grew its position in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after purchasing an additional 25 shares during the last quarter. TFC Financial Management Inc. grew its position in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys during the 3rd quarter worth approximately $27,000. SOA Wealth Advisors LLC. purchased a new stake in Synopsys during the 3rd quarter worth approximately $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys in the 4th quarter valued at $28,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Stock Down 0.5%

SNPS stock opened at $498.54 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The firm's fifty day simple moving average is $427.25 and its 200-day simple moving average is $444.89. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The company has a market capitalization of $95.50 billion, a P/E ratio of 77.41, a price-to-earnings-growth ratio of 4.09 and a beta of 1.15.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.41 billion during the quarter, compared to analysts' expectations of $2.39 billion. During the same period in the previous year, the business posted $3.03 EPS. The business's revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 10.3 earnings per share for the current year.

Analyst Upgrades and Downgrades

SNPS has been the topic of several recent research reports. Needham & Company LLC reaffirmed a "buy" rating on shares of Synopsys in a report on Thursday, February 26th. Wells Fargo & Company dropped their price objective on shares of Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a report on Thursday, February 26th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Synopsys in a report on Thursday, January 22nd. Piper Sandler dropped their price objective on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Finally, The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the company a "buy" rating in a report on Wednesday, February 25th. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $531.00.

Read Our Latest Analysis on SNPS

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.

These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines